Low-dose Combination Therapy: an Important First-line Treatment in the Management of Hypertension
Overview
Authors
Affiliations
Cho M, Oh E, Ahn B, Yoon M Transl Clin Pharmacol. 2023; 31(3):154-166.
PMID: 37810629 PMC: 10551747. DOI: 10.12793/tcp.2023.31.e15.
Therapeutic strategies against hDOT1L as a potential drug target in MLL-rearranged leukemias.
Banday S, Farooq Z, Ganai S, Altaf M Clin Epigenetics. 2020; 12(1):73.
PMID: 32450905 PMC: 7249331. DOI: 10.1186/s13148-020-00860-2.
Schaffer A, Pearson S, Buckley N Br J Clin Pharmacol. 2016; 82(4):1134-45.
PMID: 27302475 PMC: 5137838. DOI: 10.1111/bcp.13043.
Fujita M, Sasayama S, Terasaki F, Mitani S, Morimoto T, Yamazaki T Heart Vessels. 2010; 25(6):453-9.
PMID: 20922538 DOI: 10.1007/s00380-010-0012-5.
Moore M J Clin Hypertens (Greenwich). 2009; 11(1):42-5.
PMID: 19125858 PMC: 8673393. DOI: 10.1111/j.1751-7176.2008.00063.x.